אימטיניב טבע 100 מג
teva pharmaceutical industries ltd, israel - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 100 mg - imatinib
אימטיניב טבע 400 מג
teva pharmaceutical industries ltd, israel - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 400 mg - imatinib
גליבק 400 מג
novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 400 mg - imatinib
אימטיניב תרו 100 מג
taro international ltd, israel - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 100 mg - imatinib
אימטיניב תרו 400 מג
taro international ltd, israel - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 400 mg - imatinib
גליבק 100 מ"ג כמוסות
novartis pharma services ag - imatinib as mesylate 100 mg - capsules - imatinib - treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ - cml) in chronic phase, accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist).
גליבק ® 100 מ"ג
novartis pharma services ag - imatinib as mesylate 100 mg - film coated tablets - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l
ספרייסל 100 מג
bristol, myers squibb (israel) limited, israel - dasatinib - טבליות מצופות פילם - dasatinib 100 mg - dasatinib - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
סוטנט 37.5 מ"ג
pfizer pharmaceuticals israel ltd - sunitinib as malate 37.5 mg - capsules - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
ספרייסל 20 מג
bristol, myers squibb (israel) limited, israel - dasatinib - טבליות מצופות פילם - dasatinib 20 mg - dasatinib